Drugmaker files suit to block Nebraska from using execution drugs

Drugmaker files suit to block Nebraska from using execution drugs

An Illinois-based pharmaceutical company has filed a lawsuit to prevent Nebraska from using lethal injection drugs next week in what would be the state’s first execution since 1997. The federal lawsuit filed late Tuesday by Fresenius Kabi, a manufacturer and supplier of intravenous generic drugs, said two of the drugs in Nebraska’s execution protocol, cisatracurium […]

Teva's American Dream Boat is Sinking

Teva's American Dream Boat is Sinking

Teva Pharmaceutical Industries Ltd. published its second quarter reports for 2018 on Thursday, painting a cautiously optimistic picture with profit that exceeded analyst expectations and an increased guideline for the year. In actuality, much of the company’s profit margin was the result of a one-off income related to a patent infringement case, and though Teva […]

Humana Sues 37 Drug Makers, Alleges Conspiracy to Fix Prices of Certain Generics

Humana Sues 37 Drug Makers, Alleges Conspiracy to Fix Prices of Certain Generics

The lawsuit alleges that the pharmaceutical companies have conspired to fix, increase, stabilize, and/or maintain the price of a range of generic drugs, including antidepressants and beta-blockers. Humana has filed a lawsuit against dozens of pharmaceutical companies for allegedly conspiring to fix the prices of certain widely-used generic drugs, ranging from antidepressants to beta-blockers for heart […]

Mylan Is Weighing Options It May Not Have

Mylan Is Weighing Options It May Not Have

Max Nisen is a Bloomberg Opinion columnist covering biotech, pharma and health care. He previously wrote about management and corporate strategy for Quartz and Business Insider. Read more opinion Follow @MaxNisen on Twitter Mylan NV had a surprise for investors on Wednesday to go along with the disappointing second-quarter results and slashed full-year guidance it reported:  […]

Humana sues drugmakers alleging generic price-fixing scheme

Humana sues drugmakers alleging generic price-fixing scheme

Dive Brief: Health insurance giant Humana has added its own accusations to ongoing state and federal antitrust probes of the generic drug industry, claiming in a civil lawsuit that more than two dozen pharmaceutical companies colluded to fix prices. The company filed a 273-page racketeering suit on Aug. 3 in the U.S. District Court for the […]

President Donald J. Trump is Addressing the Healthcare Issues Left by the Past Administration

President Donald J. Trump is Addressing the Healthcare Issues Left by the Past Administration

Quote The American people deserve a healthcare system that takes care of them — not one that taxes and takes advantage of our patients and our consumers and our citizens. President Donald J. Trump ADDRESSING OBAMACARE’S FAILURES: President Donald J. Trump’s efforts to bring back flexibility and affordability to American health insurance are remedying the […]

Mylan stock drops 3% after wipeout of a second quarter

Mylan stock drops 3% after wipeout of a second quarter

Mylan NV’s second-quarter financial results almost couldn’t have been worse. The generic drugmaker reported worse-than-expected quarterly profit and revenue, and slashed its expectations for the year. Shares dropped almost 3% in midday trade, with trading volume nearly four times that of the 30-day average. Mylan’s […]

Humana files suit against 37 drugmakers, accusing them of price fixing

Humana files suit against 37 drugmakers, accusing them of price fixing

Humana has brought a lawsuit against 37 pharmaceutical companies, including Novartis, Mylan, and Teva, alleging price fixing for numerous generic drugs. The conspiracy increased the profits of the drugmakers and others working with them at the expense of consumers, the government, and private payers such as Humana, the lawsuit said. Humana wants to recover damages […]

Mylan to Weigh Its Options as North American Sales Plummet

Mylan to Weigh Its Options as North American Sales Plummet

Generic drug giant Mylan NV said that it would review its options as the company continues to grapple with declining prices for many of its products in the U.S. Drugmakers like Mylan that produce lower-cost versions of brand-name medicines have been grappling with plummeting prices for the past two years. The company said on Wednesday […]

The Size of the 340B Program and Its Impact on Manufacturer Revenues

As policymakers weigh changes to the 340B Drug Discount Program, which allows certain hospitals and clinics to purchase drugs at discounted prices, they have sought information on the size of the program. Here, we estimate the overall size of the program, the impact of 340B discounts on drug sales, and the impact of 340B discounts […]